Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04449432 · ClinicalTrials.gov registry record · NA
Goals for Reaching Optimal Wellness: GROWell
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 480
- Enrollment target
NCT04449432: Completed NA study, sponsored by University of California, Davis.
NCT04449432 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 480 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04449432, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
Study Summary
Despite the negative consequences to maternal-child health from women gaining too much weight during pregnancy, up to 62% of overweight and obese women gain more pregnancy weight than is recommended. This project will establish the efficacy of Goals for Reaching Optimal Wellness (GROWell), an mHealth tool for achieving appropriate pregnancy weight gain and promoting postpartum weight loss among women who enter pregnancy overweight or obese. GROWell will fill a gap in research and clinical care by providing a validated, standalone mHealth tool for weight control during pregnancy and postpartum, which is a currently lacking resource.
Primary Outcome
Gestational weight gain will be calculated as: \[weight(delivery) - weight(preconception)\]. Women will be categorized as gaining excess gestational weight if they started pregnancy as overweight and gained more than 25 pounds or started pregnancy as obese and gained more than 20 pounds.
Interventions
- BEHAVIORAL GROWell (Interactive Obesity Treatment Approach)
- BEHAVIORAL Attention Support Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2020-12-14 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT04449432 record still lists
NCT04449432 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which GROWell (Interactive Obesity Treatment Approach) is the first listed.
NCT04449432 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04449432 about?
NCT04449432 is a clinical study titled "Goals for Reaching Optimal Wellness: GROWell". Despite the negative consequences to maternal-child health from women gaining too much weight during pregnancy, up to 62% of overweight and obese women gain more pregnancy weight than is recommended. This project will establish the efficacy of Goals for Reaching Optimal Wellness (GROWell), an mHealt...
What is the current status of trial NCT04449432?
This trial is currently completed. It is a NA study. The enrollment target is 480 participants. The study started on 2020-12-14. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04449432?
The interventions under investigation include: GROWell (Interactive Obesity Treatment Approach) (BEHAVIORAL), Attention Support Control (BEHAVIORAL).
Who is sponsoring clinical trial NCT04449432?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04449432's enrollment target sits among peer trials
480 216th of 2000 higher than 1,783 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI